Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp
Start free

Concentrix Corporation (CNXC) SEC Filings & Earnings Calls

EquiReason read 20 Concentrix Corporation SEC filings in the last 12 months. Latest: 10-Q on 2026-10-07 — Concentrix reported a GAAP net loss of $988M for Q3 FY2026, driven by a $1.05B goodwill impairment, with revenue declining 1.2% YoY; non-GAAP metrics showed slight improvement..

Source: SEC EDGAR filings · figures as of 2026-08-31 · read by EquiReason

CNXCConcentrix CorporationFollow CNXC — free
Information Technology Services · Technology
—
Price chart with a free account
Market cap
2.0B
P/E TTM
—
Dividend yield
4.6%
52-week
—
Next earnings
11 Jan, in 78 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

7 Oct 202610-QConcentrix reported a GAAP net loss of $988M for Q3 FY2026, driven by a $1.05B goodwill impairment, with revenue declining 1.2% YoY; non-GAAP metrics showed slight improvement.earningsopen

Figures in the filing · each found in the filing text

Revenue · Q3-2026$2.45B-1% y/y
Net income (loss) · Q3-2026$-988M-1221% y/y
Operating income (loss) · Q3-2026$-910M-719% y/y
Adjusted EBITDA · Q3-2026$363M+1% y/y
Free cash flow · 9M-2026$294M+1% y/y
Diluted EPS (GAAP) · Q3-2026$-16.24-1312% y/y
Non-GAAP Diluted EPS · Q3-2026$2.92+5% y/y
Gross margin · Q3-202634.6%
Operating cash flow · 9M-2026$443M-4% y/y

Risks flagged

Goodwill impairment risk

“As a result of the quantitative analysis performed, the carrying value of the Company’s reporting unit was determined to exceed its fair value, resulting in a non-cash goodwill impairment charge of $1,050,000.” · word for word

Client concentration and demand risk

“Revenue in our technology and consumer electronics vertical decreased by 10.0%, primarily due to decreases in revenue for certain larger clients in the vertical.” · word for word

Restructuring execution risk

“The Company recorded severance costs of $31,429 and $91,650 for the three and nine months ended August 31, 2026, respectively, primarily related to the Company’s cost reduction initiatives. These actions affected approximately 30,000 employees.” · word for word

Foreign exchange risk

“Foreign currency exchange rates had a negative impact of $16.2 million, or 0.7%, on revenue for the period.” · word for word

Leverage and debt service risk

“Total long-term debt, net $3,925,373 as of August 31, 2026.”
Read the original on SEC EDGAR ↗
29 Sep 20268-K · 2.02Concentrix Q3 2026 revenue $2,453.7M (-1.2% YoY), non-GAAP op income $309M, adj EBITDA $363M, non-GAAP EPS $2.92. Includes $1.05B goodwill impairment. Guidance: Q4 rev $2.41-2.46B, FY rev $9.827-9.877B, adj FCF $630-650M.earningsopen

Figures in the filing · each found in the filing text

Revenue · Q3-2026$2.45B-1% y/y
Non-GAAP operating income · Q3-2026$309M+1% y/y
Adjusted EBITDA · Q3-2026$363M+1% y/y
Non-GAAP diluted EPS · Q3-2026$2.92+5% y/y
Adjusted free cash flow · Q3-2026$218M
Dividend per share · Q4-2026$0.37

Guidance

Q4 FY2026 revenue $2.41-2.46B; FY2026 revenue $9.827-9.877B; Q4 non-GAAP op income $310-320M; FY non-GAAP op income $1,206-1,216M; Q4 non-GAAP EPS $2.86-2.98; FY non-GAAP EPS $10.97-11.09; FY adj FCF $630-650M

Revenue guidance implies continued decline; margin expansion expected; management tone positive on AI-driven transformation

Risks flagged

Goodwill impairment of $1.05B signals overpayment for past acquisitions; stock price decline

“non-cash goodwill impairment charge of $1,050.0 million primarily resulting from the trading range for the Company’s stock price and market capitalization” · word for word

Revenue decline of 1.2% YoY; guidance implies further decline in Q4

“Revenue of $2,453.7 million, a decrease of (1.2)% year-on-year... Q4 revenue guidance $2.41-2.46B implies decline”
Read the original on SEC EDGAR ↗
18 Sep 20268-K · 5.02Concentrix announces EVP Customer Success Cormac Twomey will step down effective Dec 31, 2026; transition support through Feb 2027.open

Risks flagged

Loss of a senior customer success executive may temporarily affect client relationships or retention.

“Departure of EVP Customer Success; transition support in place.”
Read the original on SEC EDGAR ↗
24 Jul 20268-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportopen

Risks flagged

No material financial or operational risk identified; severance plan update is standard governance practice.

“Plan aligns with market practice; no financial metrics or changes in executive roles disclosed.”
Read the original on SEC EDGAR ↗
2 Jul 202610-QRevenue $2.46B (+2% y/y); Net income $55M (+31% y/y); Operating cash flow $175M (-27% y/y)open

Figures in the filing · each found in the filing text

Revenue · Q2-2026$2.46B+2% y/y
Net income · Q2-2026$55M+31% y/y
Operating cash flow · 6M-2026$175M-27% y/y
Free cash flow · 6M-2026$73M-45% y/y
Non-GAAP operating income · Q2-2026$292M-4% y/y
Adjusted EBITDA · Q2-2026$347M-3% y/y
Non-GAAP diluted EPS · Q2-2026$2.63-3% y/y

Risks flagged

Margin compression from wage inflation and restructuring

“Gross margin % 33.4% vs 35.1%; operating margin 3.9% vs 6.1%.”

Client concentration and revenue volatility

“Revenue in technology and consumer electronics vertical decreased by 5.8%, primarily due to decreases in revenue for certain larger clients in the vertical.”

High leverage and debt service costs

“Interest expense and finance charges, net $68.1M (three months ended May 31, 2026).”

Foreign currency exposure

“Approximately 90% of consolidated revenue generated from non-U.S. operations.”
Read the original on SEC EDGAR ↗
29 Jun 20268-K · 2.02Revenue $2.46B (+2% y/y); Operating income $95M (-36% y/y); Non-GAAP operating income $292M (-4% y/y); Guidance: Q3 revenue $2.465B-$2.490B; FY revenue $9.925B-$10.025B; FY adjusted free cash flow $630M-$650Mearningsopen

Figures in the filing · each found in the filing text

Revenue · Q2-2026$2.46B+2% y/y
Operating income · Q2-2026$95M-36% y/y
Non-GAAP operating income · Q2-2026$292M-4% y/y
Net income · Q2-2026$55M+31% y/y
Non-GAAP net income · Q2-2026$169M-6% y/y
Adjusted EBITDA · Q2-2026$347M-3% y/y
Cash flow from operations · Q2-2026$258M
Adjusted free cash flow · Q2-2026$242M
Diluted EPS · Q2-2026$0.86+37% y/y
Non-GAAP diluted EPS · Q2-2026$2.63-3% y/y

Guidance

Q3 revenue $2.465B-$2.490B; FY revenue $9.925B-$10.025B; FY adjusted free cash flow $630M-$650M

Guidance reaffirmed with modest revenue growth expectations; margin pressure continues; strong cash flow generation.

Risks flagged

Margin compression from investments and mix shift.

“Non-GAAP operating margin down 70 bps to 11.9%”

Foreign exchange headwind on revenue.

“75-basis point negative impact of foreign exchange rates compared with prior year period” · word for word
Read the original on SEC EDGAR ↗
1 May 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)SEC ↗
1 May 2026SC 13D/AGBL group sold 6M shares of CNXC in a block trade, reducing stake to 4.55% and ceasing to be a 5% holder.open

Risks flagged

Major shareholder selling

“On April 29, 2026, Sapiens sold 6,000,000 shares of Common Stock for $22.25 per share, in a block trade pursuant to Rule 144.” · word for word
Read the original on SEC EDGAR ↗
1 May 2026SC 13D/AGBL group sold 6M shares of CNXC in a block trade, reducing stake to 4.55% and ceasing to be a 5% holder.open

Risks flagged

Major shareholder selling

“On April 29, 2026, Sapiens sold 6,000,000 shares of Common Stock for $22.25 per share, in a block trade pursuant to Rule 144.” · word for word
Read the original on SEC EDGAR ↗
3 Apr 202610-QQ1 2026 revenue grew 5.4% YoY but net income fell 69.3% and operating cash flow turned negative, with significant margin compression.earningsopen

Figures in the filing · each found in the filing text

Revenue · Q1-2026$2.50B+5% y/y
Net Income · Q1-2026$22M-69% y/y
Adjusted EBITDA · Q1-2026$348M-7% y/y
Operating Cash Flow · Q1-2026$-83M

Risks flagged

Margin compression from wage inflation and restructuring

“Gross margin % 34.0 % 36.1 %” · word for word

Negative operating cash flow

“Net cash used in operating activities was $83.2 million” · word for word

Tariff uncertainty impacting client demand

“The tariff environment remains dynamic, and we cannot predict with certainty the effect of future changes in global trade policy and tariffs on our clients’ operations and demand for our services in future periods.” · word for word
Read the original on SEC EDGAR ↗
27 Mar 20268-K · 5.02, 5.07Additional shares authorized 3,700,000open

Figures in the filing · each found in the filing text

Additional shares authorized · point_in_time3,700,000

Risks flagged

Potential dilution from increased share authorization.

“3,700,000 additional shares authorized for issuance under stock incentive plan.”
Read the original on SEC EDGAR ↗
24 Mar 20268-K · 2.02Revenue $2.50B (+5% y/y); Operating income $119M (-30% y/y); Non-GAAP operating income $295M (-8% y/y); Guidance: Revenue guidance $10.035B-$10.180B; non-GAAP EPS $11.48-$12.07earningsopen

Figures in the filing · each found in the filing text

Revenue · Q1-2026$2.50B+5% y/y
Operating income · Q1-2026$119M-30% y/y
Non-GAAP operating income · Q1-2026$295M-8% y/y
Net income · Q1-2026$22M-69% y/y
Non-GAAP net income · Q1-2026$168M-11% y/y
Adjusted EBITDA · Q1-2026$348M-7% y/y
Diluted EPS · Q1-2026$0.33-68% y/y
Non-GAAP diluted EPS · Q1-2026$2.61-7% y/y

Guidance

Revenue guidance $10.035B-$10.180B; non-GAAP EPS $11.48-$12.07

Full-year guidance maintained; revenue growth expected 1.5%-3.0% constant currency; margin pressure from cost structure.

Risks flagged

Margin pressure from cost structure.

“Operating margin down 240 bps; non-GAAP operating margin down 180 bps.”
Read the original on SEC EDGAR ↗
23 Mar 20268-K · 1.01, 2.03Concentrix increased its accounts receivable securitization facility from $700M to $750M and extended the termination date to March 2028, a modest increase in committed liquidity.SEC ↗
24 Feb 20268-K · 1.01, 2.03Concentrix issued $600M 6.500% Senior Notes due 2029, using proceeds to redeem $600M of 6.650% Notes due 2026, extending maturity and refinancing near-term debt.open

Figures in the filing · each found in the filing text

aggregate principal amount of new notes · Q1-2026$600M
interest rate on new notes · Q1-20266.5%
interest rate on redeemed notes · Q1-20266.7%

Risks flagged

New notes have a step-up coupon if credit ratings are downgraded, increasing interest cost risk.

“The interest rate payable on the Notes will be subject to adjustment from time to time if any of Moody’s, S&P or Fitch downgrades the debt rating applicable to the Notes.” · word for word
Read the original on SEC EDGAR ↗
13 Feb 2026DEF 14AConcentrix filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting, disclosing fiscal 2025 financial results, executive compensation details, and a proposal to increase the equity incentive plan share reserve by 3.7 milliopen

Figures in the filing · each found in the filing text

Revenue · FY2025$9.83B+2% y/y
Non-GAAP operating income · FY2025$1.25B-5% y/y
Non-GAAP operating margin · FY202512.8%
Adjusted EBITDA · FY2025$1.47B-6% y/y
Adjusted EBITDA margin · FY202515.0%
Net income (loss) · FY2025$-1.28B
Operating income (loss) · FY2025$-918M

Risks flagged

Goodwill impairment risk

“Net loss of $(1,278.9) for fiscal year 2025 reflects a non-cash goodwill impairment charge of $1,523.3 million in the fourth quarter of 2025 primarily resulting from the trading range for our stock price and market capitalization.” · word for word

Margin compression

“Non-GAAP operating margin (1) 12.8 % 13.7 % (90) bps ... Adjusted EBITDA margin (1) 15.0 % 16.2 % (120) bps” · word for word

Underperformance of long-term incentive goals

“For the three-year performance-period ended November 30, 2025, the NEOs earned 11.67% of the PRSUs granted in January 2023” · word for word

Dilution from equity compensation

“At January 31, 2026, there were 769,067 shares remaining available for issuance under the 2020 Plan, representing 1.26% of our outstanding Common Stock as of that date. ... the 2020 Plan Amendment will provide us with an increased share reserve that will allow us to make equity awards ... for approximately two annual equity grant cycles.” · word for word
Read the original on SEC EDGAR ↗
13 Feb 20268-K · 8.01Principal amount of senior notes issued $600M; principal amount of notes redeemed $600Mopen

Figures in the filing · each found in the filing text

principal amount of senior notes issued · Q1-2026$600M
principal amount of notes redeemed · Q1-2026$600M

Risks flagged

Refinancing risk; new notes have higher coupon (6.500% vs 6.650% but longer maturity).

“Issuance of $600M 6.500% notes due 2029; redemption of 6.650% notes due 2026.”
Read the original on SEC EDGAR ↗
30 Jan 2026SC 13D/ASchedule 13D/A: FINPAR VI SA 14.24%SEC ↗
28 Jan 202610-KRevenue $9.83B (+2% y/y); Net income (loss) $-1.28B; Gross margin % 35open

Figures in the filing · each found in the filing text

Revenue · FY2025$9.83B+2% y/y
Net income (loss) · FY2025$-1.28B
Gross margin % · FY202535.0%
Adjusted EBITDA · FY2025$1.47B-6% y/y
Adjusted EBITDA margin · FY202515.0%
Non-GAAP diluted EPS · FY2025$11.22-2% y/y
Goodwill · FY2025$3.67B

Risks flagged

Goodwill impairment risk

“the carrying value of our reporting unit was determined to exceed the fair value, resulting in a non-cash goodwill impairment charge of $1,523.3 million for the fiscal year ended November 30, 2025” · word for word

High leverage

“As of November 30, 2025, we had approximately $4.65 billion of indebtedness prior to debt issuance costs” · word for word

Foreign exchange risk

“approximately 89% and 88%, respectively, of our consolidated revenue was generated from our non-U.S. operations” · word for word
Read the original on SEC EDGAR ↗
13 Jan 20268-K · 2.02Revenue $9.83B (+2% y/y); Revenue $2.55B (+4% y/y); Non-GAAP operating income $323M (-7% y/y); Guidance: Q1 FY2026 revenue guidance $2.475B-$2.500Bearningsopen

Figures in the filing · each found in the filing text

Revenue · FY2025$9.83B+2% y/y
Revenue · Q4-2025$2.55B+4% y/y
Non-GAAP operating income · Q4-2025$323M-7% y/y
Adjusted EBITDA · Q4-2025$379M-6% y/y
Non-GAAP diluted EPS · Q4-2025$2.95-10% y/y
Cash flow from operations · FY2025$807M
Adjusted free cash flow · FY2025$626M

Guidance

Q1 FY2026 revenue guidance $2.475B-$2.500B

Revenue guidance exceeded in FY2025; FY2026 guidance indicates ongoing growth and adjusted free cash flow expansion, but margins under pressure.

Risks flagged

Goodwill impairment of $1.52 billion indicates potential overpayment for acquisitions or declining market valuation.

“Non-cash goodwill impairment charge of $1,523.3 million primarily resulting from the trading range for the Company’s stock price and market capitalization.” · word for word
Read the original on SEC EDGAR ↗
7 Nov 2025SC 13D/ASchedule 13D/A: Impactive Capital LP 4.9%SEC ↗

Concentrix Corporation — questions

What did Concentrix Corporation file recently?
20 SEC filings in the last 12 months. Latest: 10-Q on 2026-10-07 — Concentrix reported a GAAP net loss of $988M for Q3 FY2026, driven by a $1.05B goodwill impairment, with revenue declining 1.2% YoY; non-GAAP metrics showed slight improvement.

Every figure on this page comes from Concentrix Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.